Compare VRE & QDEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VRE | QDEL |
|---|---|---|
| Founded | 1949 | 1979 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Medical Specialities |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.7B |
| IPO Year | 1994 | N/A |
| Metric | VRE | QDEL |
|---|---|---|
| Price | $14.75 | $26.76 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 3 | 6 |
| Target Price | $18.67 | ★ $40.00 |
| AVG Volume (30 Days) | 592.8K | ★ 990.6K |
| Earning Date | 02-23-2026 | 02-11-2026 |
| Dividend Yield | ★ 2.14% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.68 | N/A |
| Revenue | $291,348,000.00 | ★ $2,714,400,000.00 |
| Revenue This Year | $4.85 | N/A |
| Revenue Next Year | N/A | $2.28 |
| P/E Ratio | $23.79 | ★ N/A |
| Revenue Growth | ★ 6.39 | N/A |
| 52 Week Low | $13.69 | $19.50 |
| 52 Week High | $17.18 | $46.24 |
| Indicator | VRE | QDEL |
|---|---|---|
| Relative Strength Index (RSI) | 47.50 | 37.67 |
| Support Level | $14.61 | $27.19 |
| Resistance Level | $15.23 | $35.58 |
| Average True Range (ATR) | 0.32 | 2.03 |
| MACD | -0.01 | -0.88 |
| Stochastic Oscillator | 29.26 | 9.93 |
Veris Residential Inc is a fully-integrated, self-administered and self-managed real estate investment trust (REIT). The company owns and operates a real estate portfolio comprised predominantly of multifamily rental properties located mainly in the Northeast and Class A office properties. The company performs substantially all real estate management, leasing, acquisition and development on an in-house basis. The properties are in three states in the Northeast, plus the District of Columbia. The company operates in two industry segments multifamily real estate & services and commercial & other real estate. The majority of revenue is from Multifamily real estate services.
QuidelOrtho Corp is engaged in the development, manufacturing and marketing of rapid diagnostic testing solutions. The company is engaged in immunoassay and molecular testing, clinical chemistry and transfusion medicine which helps clinicians and patients to make decisions across the globe. Geographically the company has its presence in North America, EMEA, China and Other countries. It generates majority if its revenue from North America.